Skip to main content
Log in

Response to ‘How to define disease severity accurately in patients with familial Mediterranean fever’

  • Correspondence
  • Published:
Rheumatology International Aims and scope Submit manuscript
  • 2 Altmetric

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Piskin D, Demirkaya E (2020) How to define disease severity accurately in patients with familial Mediterranean fever. Rheum Int. https://doi.org/10.1007/s00296-020-04638-w

    Article  Google Scholar 

  2. Karadag SG, Sönmez HE, Tanatar A, Çakmak F, Çakan M, Aktay Akaz N (2020) Profile of new referrals to a single pediatric rheumatology center in Turkey. Rheumatol Int 40:313–321

    Article  Google Scholar 

  3. Tanatar A, Sönmez HE, Karadağ ŞG, Çakmak F, Çakan M, Demir F, Sözeri B, Ayaz NA (2020) Performance of tel-hashomer, livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center. Rheumatol Int 40:21–27

    Article  CAS  Google Scholar 

  4. Pras E, Livneh A, Balow JE Jr, Pras E, Kastner DL, Pras M, Langevitz P (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219

    Article  CAS  Google Scholar 

  5. Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A, Shtrasburg S, Rabinovitz E, Livneh A (2005) Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 35:57–64

    Article  Google Scholar 

  6. Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T (2009) Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 68:246–248

    Article  CAS  Google Scholar 

  7. Kalkan G, Demirkaya E, Acikel CH et al (2012) Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one? Rheumatology (Oxford) 51:743–748

    Article  CAS  Google Scholar 

  8. Demirkaya E, Acikel C, Hashkes P et al (2016) Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). Ann Rheum Dis 75:1051–1056

    Article  Google Scholar 

Download references

Funding

No specific funding was received from any funding bodies in the public, commercial or not for-profit sectors to carry out the work described in this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nuray Aktay Ayaz.

Ethics declarations

Conflicts of interest

The authors have declared no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aktay Ayaz, N., Tanatar, A., Karadağ, Ş.G. et al. Response to ‘How to define disease severity accurately in patients with familial Mediterranean fever’. Rheumatol Int 41, 239–240 (2021). https://doi.org/10.1007/s00296-020-04656-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-020-04656-8

Navigation